Fiducial-free CyberKnife stereotactic body radiation therapy (SBRT) for single vertebral body metastases: acceptable local control and normal tissue tolerance with 5 fraction approach

@inproceedings{Gill2012FiducialfreeCS,
  title={Fiducial-free CyberKnife stereotactic body radiation therapy (SBRT) for single vertebral body metastases: acceptable local control and normal tissue tolerance with 5 fraction approach},
  author={Beant Singh Gill and Eric K Oermann and Andrew Ju and Simeng Suy and Xia Yu and Jennifer S. Rabin and Christopher G Kalhorn and Mani Nathan Nair and J M Voyadzis and Keith Robert Unger and Sean Patrick Collins and K. William Harter and Brian T. Collins},
  booktitle={Front. Oncol.},
  year={2012}
}
This retrospective analysis examines the local control and toxicity of five-fraction fiducial-free CyberKnife stereotactic body radiation therapy (SBRT) for single vertebral body (VB) metastases. All patients had favorable performance status (ECOG 0-1), oligometastatic disease, and no prior spine irradiation. A prescribed dose of 30-35 Gy was delivered in five fractions to the planning target volume (PTV) using the CyberKnife with X-sight spine tracking. Suggested maximum spinal cord and… CONTINUE READING

References

Publications referenced by this paper.
Showing 1-10 of 24 references

Fiducial-free CyberKnife stereotactic body radiation therapy for single vertebral body metastases

  • MN Nair, J-M Voyadzis, K Unger, SP Collins, KW Harter, BT Collins
  • 2012

Radiation Oncology, a specialty of Frontiers in Oncology

  • Gill, Oermann, +9 authors Harter
  • 2012

Similar Papers

Loading similar papers…